▶ 調査レポート

世界の抗凝固薬産業2020-2026

• 英文タイトル:Global Anticoagulant Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界の抗凝固薬産業2020-2026 / Global Anticoagulant Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3010980資料のイメージです。• レポートコード:D0MA3010980
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥524,300 (USD4,900)▷ お問い合わせ
  Multi User¥786,450 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,048,600 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、抗凝固薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、抗凝固薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(NOAC、ヘパリン、ワルファリン、その他)、用途別市場規模(病院、薬局、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・抗凝固薬の種類別市場2015-2026:NOAC、ヘパリン、ワルファリン、その他
・抗凝固薬の用途別市場2015-2026:病院、薬局、その他
・抗凝固薬の北米市場分析
・抗凝固薬のアジア市場分析
・抗凝固薬の中南米市場分析
・抗凝固薬の中東・アフリカ市場分析
・関連企業情報:Bristol-Myers Squibb、Bayer、Pfizer、Johnson & Johnson、Sanofi、Boehringer Ingelheim、Daiichi Sankyo
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
In 2019, the global Anticoagulant Drugs market size was US$ 27110 million and is forecast to US$ 37780 million in 2026, growing at a CAGR of 4.8% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anticoagulant Drugs.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anticoagulant Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anticoagulant Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anticoagulant Drugs market. Readers of the report can become informed about current and future trends of the global Anticoagulant Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anticoagulant Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anticoagulant Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anticoagulant Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anticoagulant Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anticoagulant Drugs market is segmented into
NOACs
Heparin
Warfarin
Others

Market Segment by Application, the Anticoagulant Drugs market is segmented into
Hospital
Pharmacy
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo

The study objectives are:
To analyze and research the global Anticoagulant Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anticoagulant Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anticoagulant Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anticoagulant Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anticoagulant Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 NOACs
1.3.3 Heparin
1.3.4 Warfarin
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Anticoagulant Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anticoagulant Drugs Revenue (2015-2026)
2.1.1 Global Anticoagulant Drugs Revenue (2015-2026)
2.1.2 Global Anticoagulant Drugs Sales (2015-2026)
2.2 Anticoagulant Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anticoagulant Drugs Sales by Regions (2015-2020)
2.2.2 Global Anticoagulant Drugs Revenue by Regions (2015-2020)
2.3 Global Top Anticoagulant Drugs Regions (Countries) Ranking by Market Size
2.4 Anticoagulant Drugs Industry Trends
2.4.1 Anticoagulant Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Anticoagulant Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anticoagulant Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anticoagulant Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Anticoagulant Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anticoagulant Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anticoagulant Drugs Sales in 2019
3.2 Global Top Manufacturers Anticoagulant Drugs by Revenue
3.2.1 Global Anticoagulant Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anticoagulant Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anticoagulant Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant Drugs as of 2019)
3.4 Global Anticoagulant Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anticoagulant Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anticoagulant Drugs Market
3.7 Key Manufacturers Anticoagulant Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anticoagulant Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Anticoagulant Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Anticoagulant Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Anticoagulant Drugs Price by Type (2015-2020)
4.1 Global Anticoagulant Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anticoagulant Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Anticoagulant Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Anticoagulant Drugs Price Forecast by Type (2021-2026)

5 Global Anticoagulant Drugs Market Size by Application
5.1 Global Anticoagulant Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Anticoagulant Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Anticoagulant Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Anticoagulant Drugs Price by Application (2015-2020)
5.2 Global Anticoagulant Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anticoagulant Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Anticoagulant Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Anticoagulant Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anticoagulant Drugs Breakdown Data by Company
6.2 North America Anticoagulant Drugs Breakdown Data by Type
6.3 North America Anticoagulant Drugs Breakdown Data by Application
6.4 North America Anticoagulant Drugs Breakdown Data by Countries
6.4.1 North America Anticoagulant Drugs Sales by Countries
6.4.2 North America Anticoagulant Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anticoagulant Drugs Breakdown Data by Company
7.2 Europe Anticoagulant Drugs Breakdown Data by Type
7.3 Europe Anticoagulant Drugs Breakdown Data by Application
7.4 Europe Anticoagulant Drugs Breakdown Data by Countries
7.4.1 Europe Anticoagulant Drugs Sales by Countries
7.4.2 Europe Anticoagulant Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anticoagulant Drugs Breakdown Data by Company
8.2 Asia Pacific Anticoagulant Drugs Breakdown Data by Type
8.3 Asia Pacific Anticoagulant Drugs Breakdown Data by Application
8.4 Asia Pacific Anticoagulant Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Anticoagulant Drugs Sales by Regions
8.4.2 Asia Pacific Anticoagulant Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anticoagulant Drugs Breakdown Data by Company
9.2 Latin America Anticoagulant Drugs Breakdown Data by Type
9.3 Latin America Anticoagulant Drugs Breakdown Data by Application
9.4 Latin America Anticoagulant Drugs Breakdown Data by Countries
9.4.1 Latin America Anticoagulant Drugs Sales by Countries
9.4.2 Latin America Anticoagulant Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anticoagulant Drugs Breakdown Data by Type
10.2 Middle East and Africa Anticoagulant Drugs Breakdown Data by Application
10.3 Middle East and Africa Anticoagulant Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Anticoagulant Drugs Sales by Countries
10.3.2 Middle East and Africa Anticoagulant Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Bristol-Myers Squibb Anticoagulant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb Anticoagulant Drugs Products and Services
11.1.5 Bristol-Myers Squibb SWOT Analysis
11.1.6 Bristol-Myers Squibb Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Bayer Anticoagulant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Bayer Anticoagulant Drugs Products and Services
11.2.5 Bayer SWOT Analysis
11.2.6 Bayer Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Pfizer Anticoagulant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Pfizer Anticoagulant Drugs Products and Services
11.3.5 Pfizer SWOT Analysis
11.3.6 Pfizer Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Johnson & Johnson Anticoagulant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Anticoagulant Drugs Products and Services
11.4.5 Johnson & Johnson SWOT Analysis
11.4.6 Johnson & Johnson Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Sanofi Anticoagulant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Sanofi Anticoagulant Drugs Products and Services
11.5.5 Sanofi SWOT Analysis
11.5.6 Sanofi Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Boehringer Ingelheim Anticoagulant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Boehringer Ingelheim Anticoagulant Drugs Products and Services
11.6.5 Boehringer Ingelheim SWOT Analysis
11.6.6 Boehringer Ingelheim Recent Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Corporation Information
11.7.2 Daiichi Sankyo Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Daiichi Sankyo Anticoagulant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Daiichi Sankyo Anticoagulant Drugs Products and Services
11.7.5 Daiichi Sankyo SWOT Analysis
11.7.6 Daiichi Sankyo Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anticoagulant Drugs Sales Channels
12.2.2 Anticoagulant Drugs Distributors
12.3 Anticoagulant Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anticoagulant Drugs Sales Forecast (2021-2026)
13.1.1 Global Anticoagulant Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Anticoagulant Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anticoagulant Drugs Sales Forecast (2021-2026)
13.2.2 North America Anticoagulant Drugs Revenue Forecast (2021-2026)
13.2.3 North America Anticoagulant Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anticoagulant Drugs Sales Forecast (2021-2026)
13.3.2 Europe Anticoagulant Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Anticoagulant Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anticoagulant Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anticoagulant Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anticoagulant Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anticoagulant Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Anticoagulant Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Anticoagulant Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anticoagulant Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anticoagulant Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anticoagulant Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Anticoagulant Drugs Key Market Segments
Table 2. Ranking of Global Top Anticoagulant Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anticoagulant Drugs Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of NOACs
Table 5. Major Manufacturers of Heparin
Table 6. Major Manufacturers of Warfarin
Table 7. Major Manufacturers of Others
Table 8. Global Anticoagulant Drugs Market Share by Application 2019-2025 (K Units)
Table 9. Global Anticoagulant Drugs Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 10. Global Anticoagulant Drugs Sales by Regions 2015-2020 (K Units)
Table 11. Global Anticoagulant Drugs Sales Market Share by Regions 2015-2020
Table 12. Global Anticoagulant Drugs Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Anticoagulant Drugs Revenue Market Share by Regions 2015-2020
Table 14. Top Anticoagulant Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Anticoagulant Drugs Key Drivers: Impact Analysis (2021-2026)
Table 17. Anticoagulant Drugs Key Challenges
Table 18. Main Points Interviewed from Key Anticoagulant Drugs Players: Views for Future
Table 19. Global Anticoagulant Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global Anticoagulant Drugs Sales Share by Manufacturers (2015-2020)
Table 21. Anticoagulant Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Anticoagulant Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Global Anticoagulant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant Drugs as of 2019)
Table 25. Key Manufacturers Anticoagulant Drugs Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 26. Key Manufacturers Anticoagulant Drugs Plants/Factories Distribution
Table 27. Key Manufacturers Anticoagulant Drugs Area Served
Table 28. Date of Key Manufacturers Enter into Anticoagulant Drugs Market
Table 29. Key Manufacturers Anticoagulant Drugs Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global NOACs Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 32. Global Heparin Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 33. Global Warfarin Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 34. Global Others Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 35. Global Anticoagulant Drugs Sales (K Units) by Type (2015-2020)
Table 36. Global Anticoagulant Drugs Sales Share by Type (2015-2020)
Table 37. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Anticoagulant Drugs Price (K Units) by Type (2015-2020)
Table 39. Global Anticoagulant Drugs Sales (K Units) by Type (2021-2026)
Table 40. Global Anticoagulant Drugs Sales Share by Type (2021-2026)
Table 41. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Anticoagulant Drugs Revenue Share by Type (2021-2026)
Table 43. Global Anticoagulant Drugs Price (K Units) by Type (2021-2026)
Table 44. Global Anticoagulant Drugs Sales (K Units) by Application (2015-2020)
Table 45. Global Anticoagulant Drugs Sales Share by Application (2015-2020)
Table 46. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Anticoagulant Drugs Price by Application 2015-2020 (USD/Unit)
Table 48. Global Anticoagulant Drugs Sales by Application (2015-2020) (K Units)
Table 49. Global Anticoagulant Drugs Sales Share by Application (2015-2020)
Table 50. Global Anticoagulant Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Anticoagulant Drugs Revenue Share by Application (2021-2026)
Table 52. Global Anticoagulant Drugs Price (K Units) by Application (2021-2026)
Table 53. North America Anticoagulant Drugs Sales by Company (2015-2020) (K Units)
Table 54. North America Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 55. North America Anticoagulant Drugs Sales by Type (2015-2020) (K Units)
Table 56. North America Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 57. North America Anticoagulant Drugs Sales by Application (2015-2020) (K Units)
Table 58. North America Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 59. North America Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 60. North America Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 61. North America Anticoagulant Drugs Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 63. Europe Anticoagulant Drugs Sales by Company (2015-2020) (K Units)
Table 64. Europe Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 65. Europe Anticoagulant Drugs Sales by Type (2015-2020) (K Units)
Table 66. Europe Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 67. Europe Anticoagulant Drugs Sales by Application (2015-2020) (K Units)
Table 68. Europe Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 69. Europe Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 70. Europe Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 71. Europe Anticoagulant Drugs Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Anticoagulant Drugs Sales by Regions (2015-2020) (K Units)
Table 74. Asia Pacific Anticoagulant Drugs Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Anticoagulant Drugs Sales by Type (2015-2020) (K Units)
Table 76. Asia Pacific Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Anticoagulant Drugs Sales by Application (2015-2020) (K Units)
Table 78. Asia Pacific Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 80. Asia Pacific Anticoagulant Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Anticoagulant Drugs Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Anticoagulant Drugs Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Anticoagulant Drugs Sales by Company (2015-2020) (K Units)
Table 84. Latin America Anticoagulant Drugs Sales Market Share by Company (2015-2020)
Table 85. Latin America Anticoagulant Drugs Sales by Type (2015-2020) (K Units)
Table 86. Latin America Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 87. Latin America Anticoagulant Drugs Sales by Application (2015-2020) (K Units)
Table 88. Latin America Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 89. Latin America Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 90. Latin America Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 91. Latin America Anticoagulant Drugs Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Anticoagulant Drugs Sales by Type (2015-2020) (K Units)
Table 94. Middle East and Africa Anticoagulant Drugs Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Anticoagulant Drugs Sales by Application (2015-2020) (K Units)
Table 96. Middle East and Africa Anticoagulant Drugs Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 98. Middle East and Africa Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Anticoagulant Drugs Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 101. Bristol-Myers Squibb Company Details
Table 102. Bristol-Myers Squibb Description and Business Overview
Table 103. Bristol-Myers Squibb Anticoagulant Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Bristol-Myers Squibb Anticoagulant Drugs Sales Growth Rate (2015-2020)
Table 105. Bristol-Myers Squibb Anticoagulant Drugs Sales Market Share in Global Market
Table 106. Bristol-Myers Squibb Recent Development
Table 107. Bayer Company Details
Table 108. Bayer Description and Business Overview
Table 109. Bayer Anticoagulant Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Bayer Anticoagulant Drugs Sales Growth Rate (2015-2020)
Table 111. Bayer Anticoagulant Drugs Sales Market Share in Global Market
Table 112. Bayer Recent Development
Table 113. Pfizer Company Details
Table 114. Pfizer Description and Business Overview
Table 115. Pfizer Anticoagulant Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Pfizer Anticoagulant Drugs Sales Growth Rate (2015-2020)
Table 117. Pfizer Anticoagulant Drugs Sales Market Share in Global Market
Table 118. Pfizer Recent Development
Table 119. Johnson & Johnson Company Details
Table 120. Johnson & Johnson Description and Business Overview
Table 121. Johnson & Johnson Anticoagulant Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Johnson & Johnson Anticoagulant Drugs Sales Growth Rate (2015-2020)
Table 123. Johnson & Johnson Anticoagulant Drugs Sales Market Share in Global Market
Table 124. Johnson & Johnson Recent Development
Table 125. Sanofi Company Details
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Anticoagulant Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Sanofi Anticoagulant Drugs Sales Growth Rate (2015-2020)
Table 129. Sanofi Anticoagulant Drugs Sales Market Share in Global Market
Table 130. Sanofi Recent Development
Table 131. Boehringer Ingelheim Company Details
Table 132. Boehringer Ingelheim Description and Business Overview
Table 133. Boehringer Ingelheim Anticoagulant Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Boehringer Ingelheim Anticoagulant Drugs Sales Growth Rate (2015-2020)
Table 135. Boehringer Ingelheim Anticoagulant Drugs Sales Market Share in Global Market
Table 136. Boehringer Ingelheim Recent Development
Table 137. Daiichi Sankyo Company Details
Table 138. Daiichi Sankyo Description and Business Overview
Table 139. Daiichi Sankyo Anticoagulant Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. Daiichi Sankyo Anticoagulant Drugs Sales Growth Rate (2015-2020)
Table 141. Daiichi Sankyo Anticoagulant Drugs Sales Market Share in Global Market
Table 142. Daiichi Sankyo Recent Development
Table 143. Anticoagulant Drugs Distributors List
Table 144. Anticoagulant Drugs Customers List
Table 145. Global Anticoagulant Drugs Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 146. Global Anticoagulant Drugs Sales Forecast by Type 2021-2026 (K Units)
Table 147. Global Anticoagulant Drugs Sales Forecast by Application 2021-2026 (K Units)
Table 148. Global Anticoagulant Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 149. Global Anticoagulant Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 150. North America Anticoagulant Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 151. North America Anticoagulant Drugs Revenue Forecast by Countries 2021-2026
Table 152. Europe Anticoagulant Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 153. Europe Anticoagulant Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 154. Asia Pacific Anticoagulant Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 155. Asia Pacific Anticoagulant Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 156. Latin America Anticoagulant Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 157. Latin America Anticoagulant Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 158. Middle East and Africa Anticoagulant Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 159. Middle East and Africa Anticoagulant Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulant Drugs Product Picture
Figure 2. Global Anticoagulant Drugs Sales Market Shar by Type 2015-2026
Figure 3. NOACs Figures
Figure 4. Heparin Figures
Figure 5. Warfarin Figures
Figure 6. Others Figures
Figure 7. Global Anticoagulant Drugs Sales Market Share by Application in 2019 & 2026
Figure 8. Hospital Use Case
Figure 9. Pharmacy Use Case
Figure 10. Others Use Case
Figure 11. Anticoagulant Drugs Report Years Considered
Figure 12. Global Anticoagulant Drugs Market Size 2015-2026 (Million US$)
Figure 13. Global Anticoagulant Drugs Sales 2015-2020 (K Units)
Figure 14. Global Anticoagulant Drugs Market Size Market Share by Regions 2015-2020
Figure 15. Global Anticoagulant Drugs Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Anticoagulant Drugs Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Anticoagulant Drugs Sales in 2019
Figure 19. Anticoagulant Drugs Value Share by Manufacturers in 2019
Figure 20. Anticoagulant Drugs Revenue Share by Manufacturers In 2019
Figure 21. Anticoagulant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Anticoagulant Drugs Revenue Share by Type (2015-2020)
Figure 23. Global Anticoagulant Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global Anticoagulant Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Anticoagulant Drugs Revenue Share by Application (2015-2020)
Figure 26. Global Anticoagulant Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America Anticoagulant Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. Canada Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 30. Europe Anticoagulant Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Russia Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Asia Pacific Anticoagulant Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Japan Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. South Korea Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. India Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Australia Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Taiwan Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Indonesia Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Thailand Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Malaysia Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Philippines Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Vietnam Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Latin America Anticoagulant Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Brazil Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Argentina Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Middle East and Africa Anticoagulant Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Saudi Arabia Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.A.E Anticoagulant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Anticoagulant Drugs Value Chain
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. North America Anticoagulant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. North America Anticoagulant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Europe Anticoagulant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. Europe Anticoagulant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Asia Pacific Anticoagulant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 71. Asia Pacific Anticoagulant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Latin America Anticoagulant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 73. Latin America Anticoagulant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Middle East and Africa Anticoagulant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 75. Middle East and Africa Anticoagulant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed